| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BRUKER CORP | Chief Accounting Officer | Common Stock | 3.47K | $165K | $47.40 | Mar 10, 2025 | Direct |
| PIERIS PHARMACEUTICALS, INC. | Chief Financial Officer | Stock Option (right to buy) | 249K | Feb 24, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BRKR | BRUKER CORP | Mar 10, 2025 | 1 | $23.7K | 4 | Mar 11, 2025 | Chief Accounting Officer |
| BRKR | BRUKER CORP | Feb 15, 2025 | 1 | $0 | 4 | Feb 19, 2025 | Chief Accounting Officer |
| BRKR | BRUKER CORP | Jan 13, 2025 | 0 | $0 | 3 | Jan 16, 2025 | Chief Accounting Officer |
| PIRS | PIERIS PHARMACEUTICALS, INC. | Feb 24, 2023 | 1 | $0 | 4 | Feb 28, 2023 | Chief Financial Officer |
| PIRS | PIERIS PHARMACEUTICALS, INC. | Feb 22, 2022 | 1 | $0 | 4 | Feb 24, 2022 | Chief Financial Officer |